Decoy Therapeutics, Inc. (DCOY)
3.11
-0.09
(-2.81%)
USD |
NASDAQ |
Aug 24, 16:00
3.11
0.00 (0.00%)
After-Hours: 20:00
Decoy Therapeutics Debt to Equity Ratio : 0.00 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.00 |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 1.813 |
| December 31, 2024 | 0.1468 |
| September 30, 2024 | 0.1124 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.032 |
| December 31, 2023 | 0.0548 |
| September 30, 2023 | 0.0755 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.0039 |
| December 31, 2020 | 0.0215 |
| September 30, 2020 | 0.0369 |
| June 30, 2020 | 0.00 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.014 |
| December 31, 2019 | 0.0475 |
| September 30, 2019 | 0.0769 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Palatin Technologies, Inc. | 0.0271 |
| Unicycive Therapeutics, Inc. | 0.0139 |
| Nuvectis Pharma, Inc. | 0.00 |
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
| Alnylam Pharmaceuticals, Inc. | 2.206 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 9.001M |
| Total Liabilities (Quarterly) | 4.680M |
| Shareholders Equity (Quarterly) | 4.321M |
| Current Ratio | 1.832 |
| Net Debt Paydown Yield | 0.59% |